NS
Nagnath Shktishiv Satpute
About Nagnath Shktishiv Satpute
Data last updated:
Nagnath Shktishiv Satpute is a Director at Canaan Lifescience Pharmaceuticals Limited (since 2021). The company operates in Pharma. Canaan Lifescience Pharmaceuticals Limited reported revenue of ₹84.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Canaan Lifescience Pharmaceuticals Limited U74999DL2017PLC325227 | Director | 26 Feb 2021 | 2017 | ₹84.2 Lakh (FY 2025) | Active |
Board colleagues of Nagnath Shktishiv Satpute
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhinav Maheshwari Sohanlal | 07956201 | Canaan Lifescience Pharmaceuticals Limited | Director |
| Yogesh Rohidas Lanke | 09076855 | Canaan Lifescience Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagnath Shktishiv Satpute
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagnath Shktishiv Satpute
Nagnath Shktishiv Satpute currently holds 1 directorship: Canaan Lifescience Pharmaceuticals Limited (Director, since 26 Feb 2021, revenue ₹84.2 Lakh (FY 2025)).
Nagnath Shktishiv Satpute was first appointed on 26 Feb 2021 as Director at Canaan Lifescience Pharmaceuticals Limited.
The current boards of Nagnath Shktishiv Satpute's companies include Abhinav Maheshwari Sohanlal (Canaan Lifescience Pharmaceuticals Limited), Yogesh Rohidas Lanke (Canaan Lifescience Pharmaceuticals Limited).